|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forner A, Llovet JM and Bruix J:
Hepatocellular carcinoma. Lancet. 379:1245–1255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
4
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Villanueva A, Newell P, Chiang DY,
Friedman SL and Llovet JM: Genomics and signaling pathways in
hepatocellular carcinoma. Semin Liver Dis. 27:55–76. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aravalli RN, Cressman EN and Steer CJ:
Cellular and molecular mechanisms of hepatocellular carcinoma: An
update. Arch Toxicol. 87:227–247. 2013. View Article : Google Scholar
|
|
7
|
Moeini A, Cornellà H and Villanueva A:
Emerging signaling pathways in hepatocellular carcinoma. Liver
Cancer. 1:83–93. 2012. View Article : Google Scholar
|
|
8
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu T, Zhu Y, Xiong Y, Ge YY, Yun JP and
Zhuang SM: MicroRNA-195 suppresses tumorigenicity and regulates
G1/S transition of human hepatocellular carcinoma cells.
Hepatology. 50:113–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li D, Liu X, Lin L, Hou J, Li N, Wang C,
Wang P, Zhang Q, Zhang P, Zhou W, et al: MicroRNA-99a inhibits
hepatocellular carcinoma growth and correlates with prognosis of
patients with hepatocellular carcinoma. J Biol Chem.
286:36677–36685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou X, Zhang CZ, Lu SX, Chen GG, Li LZ,
Liu LL, Yi C, Fu J, Hu W, Wen JM, et al: miR-625 suppresses tumour
migration and invasion by targeting IGF2BP1 in hepatocellular
carcinoma. Oncogene. 34:965–977. 2015. View Article : Google Scholar
|
|
16
|
Gedaly R, Angulo P, Hundley J, Daily MF,
Chen C, Koch A and Evers BM: PI-103 and sorafenib inhibit
hepatocellular carcinoma cell proliferation by blocking
Ras/Raf/MAPK and PI3K-AKT-mTOR pathways. Anticancer Res.
30:4951–4958. 2010.PubMed/NCBI
|
|
17
|
Chen M, Gu J, Delclos GL, Killary AM, Fan
Z, Hildebrandt MA, Chamberlain RM, Grossman HB, Dinney CP and Wu X:
Genetic variations of the PI3K-AKT-mTOR pathway and clinical
outcome in muscle invasive and metastatic bladder cancer patients.
Carcinogenesis. 31:1387–1391. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Whittaker S, Marais R and Zhu AX: The role
of signaling pathways in the development and treatment of
hepatocellular carcinoma. Oncogene. 29:4989–5005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao L and Vogt PK: Class I PI3K in
oncogenic cellular transformation. Oncogene. 27:5486–5496. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi ZM, Wang J, Yan Z, You YP, Li CY, Qian
X, Yin Y, Zhao P, Wang YY, Wang XF, et al: MiR-128 inhibits tumor
growth and angiogenesis by targeting p70S6K1. PLoS One.
7:e327092012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin M, Zhang T, Liu C, Badeaux MA, Liu B,
Liu R, Jeter C, Chen X, Vlassov AV and Tang DG: miRNA-128
suppresses prostate cancer by inhibiting BMI-1 to inhibit
tumor-initiating cells. Cancer Res. 74:4183–4195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu YD, Wang L, Sun C, Fan L, Zhu DX, Fang
C, Wang YH, Zou ZJ, Zhang SJ, Li JY, et al: Distinctive microRNA
signature is associated with the diagnosis and prognosis of acute
leukemia. Med Oncol. 29:2323–2331. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhu Y, Yu F, Jiao Y, Feng J, Tang W, Yao
H, Gong C, Chen J, Su F, Zhang Y, et al: Reduced miR-128 in breast
tumor-initiating cells induces chemotherapeutic resistance via
Bmi-1 and ABCC5. Clin Cancer Res. 17:7105–7115. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li M, Fu W, Wo L, Shu X, Liu F and Li C:
miR-128 and its target genes in tumorigenesis and metastasis. Exp
Cell Res. 319:3059–3064. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li B, Chen H, Wu N, Zhang WJ and Shang LX:
Deregulation of miR-128 in ovarian cancer promotes cisplatin
resistance. Int J Gynecol Cancer. 24:1381–1388. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G,
Fu S, Zhang Y, Feng K and Feng Y: microRNA-128 plays a critical
role in human non-small cell lung cancer tumourigenesis,
angiogenesis and lymphangiogenesis by directly targeting vascular
endothelial growth factor-C. Eur J Cancer. 50:2336–2350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dong Q, Cai N, Tao T, Zhang R, Yan W, Li
R, Zhang J, Luo H, Shi Y, Luan W, et al: An axis involving SNAI1,
microRNA-128 and SP1 modulates glioma progression. PLoS One.
9:e986512014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seca H, Lima RT, Almeida GM,
Sobrinho-Simoes M, Bergantim R, Guimaraes JE and Vasconcelos MH:
Effect of miR-128 in DNA damage of HL-60 acute myeloid leukemia
cells. Curr Pharm Biotechnol. 15:492–502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khan AP, Poisson LM, Bhat VB, Fermin D,
Zhao R, Kalyana-Sundaram S, Michailidis G, Nesvizhskii AI, Omenn
GS, Chinnaiyan AM, et al: Quantitative proteomic profiling of
prostate cancer reveals a role for miR-128 in prostate cancer. Mol
Cell Proteomics. 9:298–312. 2010. View Article : Google Scholar :
|
|
30
|
Katada T, Ishiguro H, Kuwabara Y, Kimura
M, Mitui A, Mori Y, Ogawa R, Harata K and Fujii Y: microRNA
expression profile in undifferentiated gastric cancer. Int J Oncol.
34:537–542. 2009.PubMed/NCBI
|
|
31
|
Takahashi Y, Iwaya T, Sawada G, Kurashige
J, Matsumura T, Uchi R, Ueo H, Takano Y, Eguchi H, Sudo T, et al:
Up-regulation of NEK2 by microRNA-128 methylation is associated
with poor prognosis in colorectal cancer. Ann Surg Oncol.
21:205–212. 2014. View Article : Google Scholar
|
|
32
|
Zhang X, Li HM, Liu Z, Zhou G, Zhang Q,
Zhang T, Zhang J and Zhang C: Loss of heterozygosity and
methylation of multiple tumor suppressor genes on chromosome 3 in
hepatocellular carcinoma. J Gastroenterol. 48:132–143. 2013.
View Article : Google Scholar
|
|
33
|
Gatto F, Nookaew I and Nielsen J:
Chromosome 3p loss of heterozygosity is associated with a unique
metabolic network in clear cell renal carcinoma. Proc Natl Acad Sci
USA. 111:E866–E875. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saint-Georges F, Garçon G, Escande F,
Abbas I, Verdin A, Gosset P, Mulliez P and Shirali P: Role of air
pollution Particulate Matter (PM(2.5)) in the occurrence of loss of
heterozygosity in multiple critical regions of 3p chromosome in
human epithelial lung cells (L132). Toxicol Lett. 187:172–179.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mi S, Lu J, Sun M, Li Z, Zhang H, Neilly
MB, Wang Y, Qian Z, Jin J, Zhang Y, et al: MicroRNA expression
signatures accurately discriminate acute lymphoblastic leukemia
from acute myeloid leukemia. Proc Natl Acad Sci USA.
104:19971–19976. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tao T, Li G, Dong Q, Liu D, Liu C, Han D,
Huang Y, Chen S, Xu B and Chen M: Loss of SNAIL inhibits cellular
growth and metabolism through the miR-128-mediated
RPS6KB1/HIF-1α/PKM2 signaling pathway in prostate cancer cells.
Tumour Biol. 35:8543–8550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adlakha YK and Saini N: miR-128 exerts
pro-apoptotic effect in a p53 transcription-dependent and
-independent manner via PUMA-Bak axis. Cell Death Dis. 4:e5422013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheung LW, Hennessy BT, Li J, Yu S, Myers
AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F, et al:
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer
elucidates a novel mechanism for regulation of PTEN protein
stability. Cancer Discov. 1:170–185. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jaiswal BS, Janakiraman V, Kljavin NM,
Chaudhuri S, Stern HM, Wang W, Kan Z, Dbouk HA, Peters BA, Waring
P, et al: Somatic mutations in p85α promote tumorigenesis through
class IA PI3K activation. Cancer Cell. 16:463–474. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sun M, Hillmann P, Hofmann BT, Hart JR and
Vogt PK: Cancer-derived mutations in the regulatory subunit p85α of
phosphoinositide 3-kinase function through the catalytic subunit
p110α. Proc Natl Acad Sci USA. 107:15547–15552. 2010. View Article : Google Scholar
|
|
41
|
Urick ME, Rudd ML, Godwin AK, Sgroi D,
Merino M and Bell DW: PIK3R1 (p85α) is somatically mutated at high
frequency in primary endometrial cancer. Cancer Res. 71:4061–4067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sun Y, Zhao S, Tian H, Xie X, Xiao F, Li K
and Song Y: Depletion of PI3K p85α induces cell cycle arrest and
apoptosis in colorectal cancer cells. Oncol Rep. 22:1435–1441.
2009.PubMed/NCBI
|
|
43
|
Hong M, Wilkes MC, Penheiter SG, Gupta SK,
Edens M and Leof EB: Non-Smad transforming growth factor-β
signaling regulated by focal adhesion kinase binding the p85
subunit of phosphatidylinositol 3-kinase. J Biol Chem.
286:17841–17850. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Selbach M, Schwanhäusser B, Thierfelder N,
Fang Z, Khanin R and Rajewsky N: Widespread changes in protein
synthesis induced by microRNAs. Nature. 455:58–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
